KANAN BHATT: Open Payments
NPI 1538701313 · PRINCETON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$759 in 43 payments from 6 companies in 2025. Trend: 2023 $644 · 2024 $798 · 2025 $759
Food & beverage: $759
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 16 | $405 |
| ViiV Healthcare Company | 23 | $207 |
| GlaxoSmithKline, LLC. | 1 | $94 |
| Indivior Inc. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| ABBVIE INC. | 1 | $16 |
Products named: Yeztugo, SHINGRIX, CABENUVA, DOVATO, Biktarvy, APRETUDE, SUBLOCADE, MAVYRET.
Industry payments across NJ — which companies pay providers there.
